Correlation Between Bank of America and NextCell Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and NextCell Pharma AB, you can compare the effects of market volatilities on Bank of America and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and NextCell Pharma.

Diversification Opportunities for Bank of America and NextCell Pharma

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Bank and NextCell is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Bank of America i.e., Bank of America and NextCell Pharma go up and down completely randomly.

Pair Corralation between Bank of America and NextCell Pharma

Considering the 90-day investment horizon Bank of America is expected to generate 1.12 times more return on investment than NextCell Pharma. However, Bank of America is 1.12 times more volatile than NextCell Pharma AB. It trades about 0.31 of its potential returns per unit of risk. NextCell Pharma AB is currently generating about 0.04 per unit of risk. If you would invest  4,182  in Bank of America on September 1, 2024 and sell it today you would earn a total of  569.00  from holding Bank of America or generate 13.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy91.3%
ValuesDaily Returns

Bank of America  vs.  NextCell Pharma AB

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
NextCell Pharma AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NextCell Pharma AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, NextCell Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bank of America and NextCell Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and NextCell Pharma

The main advantage of trading using opposite Bank of America and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.
The idea behind Bank of America and NextCell Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios